In the latest trading session,, 12.35 million Zomedica Corp (AMEX:ZOM) shares changed hands as the company’s beta touched 1.07. With the company’s most recent per share price at $0.15 changing hands around $0.01 or 8.71% at last look, the market valuation stands at $149.15M. ZOM’s current price is a discount, trading about -53.33% off its 52-week high of $0.23. The share price had its 52-week low at $0.12, which suggests the last value was 20.0% up since then. When we look at Zomedica Corp’s average trading volume, we note the 10-day average is 7.97 million shares, with the 3-month average coming to 4.24 million.
Analysts gave the Zomedica Corp (ZOM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ZOM as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Zomedica Corp’s EPS for the current quarter is expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zomedica Corp (AMEX:ZOM) trade information
Instantly ZOM is in green as seen in intraday trades today. With action 25.06%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -23.98%, with the 5-day performance at 25.06% in the green. However, in the 30-day time frame, Zomedica Corp (AMEX:ZOM) is 22.45% up. Looking at the short shares, we see there were 51.14 million shares sold at short interest cover period of 17.24 days.
Zomedica Corp (ZOM) estimates and forecasts
Year-over-year growth is forecast to reach 35.40% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 6.26M. 1 analysts are of the opinion that Zomedica Corp’s revenue for the current quarter will be 6.13M. The company’s revenue for the corresponding quarters a year ago was 5.48M and 6.02M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 14.20%. The estimates for the next quarter sales put growth at 1.80%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 27.70%. The 2024 estimates are for Zomedica Corp earnings to decrease by -37.14%.
ZOM Dividends
Zomedica Corp is expected to release its next quarterly earnings report on 2024-May-09.
Zomedica Corp (AMEX:ZOM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.78% of Zomedica Corp shares while 8.33% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 8.48%. There are 8.33% institutions holding the Zomedica Corp stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 3.054% of the shares, roughly 29.93 million ZOM shares worth $382.18 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 2.6742% or 26.21 million shares worth $334.65 million as of 2024-06-30.
